Clinical Trial of Ezogabine (Retigabine) on Motor Neuron Excitability in ALS

Dr. Brian Wainger, from Massachusetts General Hospital, will discuss the rationale and design of the study, describe the recent Protocol Amendment which impacts the patient population to be recruited and what is entailed by participating in the study. Dr. Wainger will also provide a brief update of the ongoing study.

Neals logo